- Lobbying
- american AND society AND of AND clinical AND oncology
Lobbying Arrangements Results for 'American Society Of Clinical Oncology'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Comprehensive Cancer Care Improvement Act, HR 1078/S 2790 |
American Society of Clinical Oncology
|
Turner & Goss LLP | |||
Details HR 913 - Clinical Treatment Act, drug pricing issues |
Peck Madigan Jones (on behalf of American Society of Clinical Oncology)
|
Tiber Creek Health Strategies, Inc. | |||
Details Issues related to oncology care, physician reimbursement, research funding, and the cost of prescription drugs. CLINICAL TREATMENT Act, HR 913. Issues related to oncology care, physician reimbursem... |
American Society of Clinical Oncology
|
Peck Madigan Jones | |||
Details Hematology and hematology/oncology public health and research issues; HR 640 Bone Marrow Failure Disease Research and Treatment Act of 2011. Medicare Physician Fee Schedule; Medicare Reimbursement... |
American Society of Hematology
|
HOLLAND & KNIGHT LLP | |||
Details Issues pertaining to the federal government's regulation and coverage of cancer care and treatments [Comprehensive Cancer Care Improvement Act (H.R. 1078) -- all provisions; Legislation pertaining ... |
American Society of Clinical Oncology
|
POWELL GOLDSTEIN LLP | |||
Details Prepared comments on the Centers for Medicare and Medicaid Services data request and access policy changes; Prepared comments on the Food and Drug Administrations Draft Guidance for Industry and Fo... |
Physician Clinical Registry Coalition
|
Powers Pyles Sutter & Verville, P.C. | |||
Details Discussions regarding patient access to radiation oncology. |
American Society for Radiation Oncology
|
Cornerstone Government Affairs, Inc. | |||
Details HR 913 - CLINICAL TREATMENT Act Implementation of the Medicare Access and CHIP Re authorization Act HR 3107 Improving Seniors' Timely Access to Care Act of 2019 Funding for the National Institute ... |
American Society of Clinical Oncology
|
in-house lobbying | |||
Details FY2024 LHHS Appropriations bill-funding for NIH/NCI Access to radioactive isotopes Support to ensure that advances in biomedical research impacting patient care are not compromised by any policies ... |
AMERICAN SOCIETY FOR RADIATION ONCOLOGY
|
in-house lobbying | |||
Details Issues related to the quality of cancer care; Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Issues pertaining to average sales price;I... |
American Society of Clinical Oncology
|
Polsinelli PC | |||
Details Issues related to the quality of cancer care [Patient Protection and Affordable Care Act (H.R. 3590); Affordable Health Care for America Act (H.R. 3962); Mammogram and MRI Availability Act (H.R. 99... |
American Society of Clinical Oncology
|
Bryan Cave LLP | |||
Details FY 2009 Labor, HHS, Education Appropriations Bills Hematology Research Medicare Physician Fee Schedule Medicare Reimbursement for Drugs and Biologicals Medicare Coverage Policies Medicare Hospital ... |
AMERICAN SOCIETY OF HEMATOLOGY
|
MARC ASSOCIATES, INC. | |||
Details Public health program funding Federal research funding Advanced Research Projects Agency for Health (ARPA-H) FY 2024 NIH funding FY 2024 AHRQ funding FY 2024 CDC funding FY 2024 funding for CDC Sic... |
American Society of Hematology
|
in-house lobbying |